Skip to main navigation Skip to search Skip to main content

Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen

  • Therese Buskas*
  • , Sampat Ingale
  • , Geert J. Boons
  • *Corresponding author for this work
  • University of Georgia
  • extern

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

(Chemical Equation Presented) A spoonful of sugar ... A carbohydrate-based fully synthetic vaccine 1, composed of a tumor-associated Tn antigen, a peptide Tepitope, and a lipopeptide (see structure), shows potential as a candidate against cancer. Incorporation of the glycolipopeptide into liposomes gave a formulation that was able to elicit a T cell dependent antibody response in mice.

Original languageEnglish
Pages (from-to)5985-5988
Number of pages4
JournalAngewandte Chemie - International Edition
Volume44
Issue number37
DOIs
Publication statusPublished - 19 Sept 2005
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antitumor agents
  • Glycopeptides
  • Liposomes
  • Solid-phase synthesis

Fingerprint

Dive into the research topics of 'Towards a fully synthetic carbohydrate-based anticancer vaccine: Synthesis and immunological evaluation of a lipidated glycopeptide containing the tumor-associated Tn antigen'. Together they form a unique fingerprint.

Cite this